Health

Famous daily anti-anxiety medication recalled all over US for ‘failed dissolution’

An anti-anxiety medication used by millions of Americans has been recalled by their distributor

Published April 16, 2026
Famous daily anti-anxiety medication recalled all over US for ‘failed dissolution’
Famous daily anti-anxiety medication recalled all over US for ‘failed dissolution’

3-milligram tablets of Xanax XR, the brand name for the drug alprazolam, sold in 60-tablet bottles were initially recalled by the distributor Viatris.

On Wednesday, April 15, the pills were recalled nationwide in the US after they "failed dissolution specifications," according to the FDA.

Advertisement

The FDA classified the recall as a Class II, indicating that "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

As per PEOPLE magazine, the pills marked as part of lot number 8177156 are impacted by the recall. The medication will be marked with an expiration date of 02/28/2027.

Anyone who has been prescribed the affected pills should stop taking them immediately, and dispose of them safely.

The pills were distributed to patients between August 27, 2024, and May 29, 2025, per the California State Board of Pharmacy.

For anyone unversed, Xanax is typically prescribed to treat symptoms of anxiety associated with several mental health conditions.

As per Cleveland Clinic, the medication, "works by helping your nervous system calm down," and is one of the most commonly prescribed benzodiazepines (a class of anti-anxiety medication) in the U.S.

Sadaf Naushad
Sadaf Naushad is a Journalist and Neurochemistry master's graduate with over four years of experience. Leveraging her scientific background, she specialises in celebrity wellness, mental health, and the psychology of lifestyle trends, bridging the gap between science and pop culture to provide expert insight into global icons' well-being.
Share this story: